Solid underlying financial performance and well-positioned for continued growth
Paris, France and Camberley, UK - 27 September 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the half year ended 30 June 2021.

http://novacyt.com/wp-content/uploads/2021/09/Novacyt-H1-results-final-.pdf

Attachments

  • Original document
  • Permalink

Disclaimer

Novacyt SA published this content on 27 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 September 2021 06:11:09 UTC.